NeuroPace (NPCE) Non-Current Assets (2020 - 2026)
NeuroPace (NPCE) recorded quarterly Non-Current Assets of $11.9 million in Q1 2026, up 3.72% quarter-over-quarter from $11.5 million in Q4 2025, and down 6.34% on a YoY basis from $12.7 million in Q1 2025.
NeuroPace (NPCE) Non-Current Assets (2020 - 2026) Analysis & Trends
NeuroPace's Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 6.34% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $47.7 million (down 11.5% YoY), while the FY2025 annual figure was $11.5 million, down 13.65% from the prior year.
- Non-Current Assets was $11.9 million for Q1 2026 at NeuroPace, up from $11.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $16.4 million in Q4 2022 to a low of $6.1 million in Q2 2022.
- Historically, Non-Current Assets has averaged $13.1 million across 5 years, with a median of $13.7 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets soared 2097.32% in 2022, then retreated 13.65% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $16.4 million in 2022, then fell by 8.91% to $14.9 million in 2023, then fell by 10.88% to $13.3 million in 2024, then retreated by 13.65% to $11.5 million in 2025, then gained by 3.72% to $11.9 million in 2026.
- The last three Non-Current Assets figures came in at $11.9 million (Q1 2026), $11.5 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | NeuroPace | 527.50 Mn | 473.52 Mn | 18.05 Mn | 11.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.92 Mn |
| Dec 31, 2025 | 11.49 Mn |
| Sep 30, 2025 | 11.93 Mn |
| Jun 30, 2025 | 12.37 Mn |
| Mar 31, 2025 | 12.73 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 13.71 Mn |
| Jun 30, 2024 | 14.16 Mn |
| Mar 31, 2024 | 14.60 Mn |
| Dec 31, 2023 | 14.93 Mn |
| Sep 30, 2023 | 15.33 Mn |
| Jun 30, 2023 | 15.72 Mn |
| Mar 31, 2023 | 16.12 Mn |
| Dec 31, 2022 | 16.39 Mn |
| Sep 30, 2022 | 16.10 Mn |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 746,000.00 |
| Sep 30, 2021 | 767,000.00 |
| Jun 30, 2021 | 570,000.00 |